Systematic review to determine whether participation in a trial influences outcome
about
Does HAART efficacy translate to effectiveness? Evidence for a trial effectClinical trials and medical care: defining the therapeutic misconceptionOpen, small-incision, or laparoscopic cholecystectomy for patients with symptomatic cholecystolithiasis. An overview of Cochrane Hepato-Biliary Group reviewsOutcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participateThe research-treatment distinction: a problematic approach for determining which activities should have ethical oversightWhen are clinical trials beneficial for study patients and future patients? A factorial vignette-based survey of institutional review board members.The clinical course of low back pain: a meta-analysis comparing outcomes in randomised clinical trials (RCTs) and observational studies.Promoting public awareness of randomised clinical trials using the media: the 'Get Randomised' campaign.What should be disclosed to research participants?Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).Improving the use of research evidence in guideline development: 7. Deciding what evidence to include.Chemotherapy-related hospitalization among community cancer center patientsReporting of participant flow diagrams in published reports of randomized trials.Reducing the confusion and controversies around pragmatic trials: using the Cardiovascular Health Awareness Program (CHAP) trial as an illustrative example.CONSORT 2010 statement: extension to randomised pilot and feasibility trialsEvaluating the efficacy of current clinical practice of adjuvant chemotherapy in postmenopausal women with early-stage, estrogen or progesterone receptor-positive, one-to-three positive axillary lymph node, breast cancer.Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials.The "number needed to treat" turns 20--and continues to be used and misusedDBCG trial 89B comparing adjuvant CMF and ovarian ablation: similar outcome for eligible but non-enrolled and randomized breast cancer patients.Reconnecting with urban youth enrolled in a randomized controlled trial and overdue for a 12-month follow-up surveyA review of reporting of participant recruitment and retention in RCTs in six major journals.Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial.Long-term prognosis in patients continuing taking antithrombotics after peptic ulcer bleeding.Comparison of survival outcomes among cancer patients treated in and out of clinical trials.Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myelomaWhat are the attitudes of strictly-orthodox Jews to clinical trials: are they influenced by Jewish teachings?Limitations of the interpretation and extrapolation of clinical trial data in kidney transplant recipients.Why take part in personalised cancer research? Patients' genetic misconception, genetic responsibility and incomprehension of stratification-an empirical-ethical examination.Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis.Use of a motivational interviewing-informed strategy in group orientations to improve retention and intervention attendance in a randomized controlled trial.Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial.Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program.Participants in research.Hospital volume and prognosis among Norwegian breast cancer patients enrolled in adjuvant trials.Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis.Must research participants understand randomization?Benefits and pitfalls of national mortality audits.Personal benefit, or benefiting others? Deciding whether to take part in clinical trials.The unbelievable rightness of being in clinical trials. Commentary.Innovative approaches to informed consent for randomized clinical trials: Identifying the ethical challenges.
P2860
Q21135313-379D662D-FD46-44D0-BACC-AFE812B51281Q21144663-251FBBB2-17D3-4B42-9CF5-B12A8CA4C4D5Q24241082-A018ABEE-5B72-449E-BA56-72A0B12DFD55Q24242288-7AEC44C5-5543-441B-864D-1606053B9435Q28283204-F102B026-F01D-4129-AE19-BB9CEB03E03FQ30275825-8497236D-BD81-4A95-9677-4150DF79FFA2Q33556594-BC6CD3FF-8338-4091-9BEE-7F9276C61567Q33633652-BB48256D-6C14-42EC-9092-97DFCDBBFE47Q34131719-F482338A-23F4-46AE-BA11-6CC23CE9B93DQ34736580-E353473F-D127-41DC-A1FB-6B5247864199Q35225188-89829862-9041-49F8-93C4-433E8BED6684Q35584511-4C4B64DE-C9EF-4FB2-A6D3-7DB03370EC88Q35677565-BE21947E-442E-448E-BD0C-CFC9DFB075F5Q36020462-B48FD159-A786-4493-9DCD-433017043AB0Q36173563-57789344-ECFF-4B19-B186-F2C644C80F73Q36278585-910F1850-CFF6-4BD5-A15A-EE770129488AQ36436428-4FB886B8-F407-4C06-9951-0C7729D0AD6EQ36856802-17CE0A27-3396-4A6C-BEB2-4CE5E4F29022Q37157593-C69BD956-C6CA-4036-A6DB-64FC4FD222EEQ37238693-08CFC043-7EB2-4FA0-B013-07DA177D1D0BQ37281406-6B214936-4FA5-41BC-8B7A-D918EEB717A4Q37340801-5102A500-B378-4906-A9AA-742AE67FF029Q37625235-C700FE51-7654-40D5-BD0C-93AF9E9FE5E1Q37696455-9D1B99F6-F8CE-4853-881C-B778FD12C1EAQ37744801-2C32E1DD-B964-4705-BD88-2306842847C7Q38069881-A726DBE1-5865-4F3A-AE0D-FF9037874C6EQ38700286-56989655-3320-47C9-A989-6ABEA176CDF2Q38832807-F2444178-700C-4F38-9B4F-4E8762D9350EQ39034162-3C5BA38F-8FC6-46F2-807C-AFA4C882E984Q39125919-BF72C5D0-3065-4D2D-8A3F-33BBCEE5A599Q39855034-0953F6CD-F28F-4D4F-A196-44F886976D41Q41334502-29DFA6AA-9D88-41EC-AFAC-9E02A662F0BDQ43058666-8F231A9E-99D9-4A2A-8B7E-C81FC39B4740Q44680209-0FC6B46C-841C-477D-A9DE-54A502E98B48Q44681764-ABF56F92-DE7F-41AB-8491-1DC4A0E1E1B2Q45067111-EB915957-6008-484F-B3CE-9C0FCCDAD4B4Q46404379-61B4B144-D12C-4574-9F70-C604D7B8F46CQ48165602-4B993AE8-EB77-4CAD-AAB9-552E41E2C708Q48292579-231CFB15-C631-4E72-A26A-C7C90DC7D6B1Q49691435-A8B70330-D9E9-4D13-A69D-98E83B661541
P2860
Systematic review to determine whether participation in a trial influences outcome
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Systematic review to determine whether participation in a trial influences outcome
@ast
Systematic review to determine whether participation in a trial influences outcome
@en
type
label
Systematic review to determine whether participation in a trial influences outcome
@ast
Systematic review to determine whether participation in a trial influences outcome
@en
prefLabel
Systematic review to determine whether participation in a trial influences outcome
@ast
Systematic review to determine whether participation in a trial influences outcome
@en
P2093
P2860
P1433
P1476
Systematic review to determine whether participation in a trial influences outcome
@en
P2093
Dianne Bryant
Doris Tove Kristoffersen
Kåre Birger Hagen
P J Devereaux
P2860
P356
10.1136/BMJ.330.7501.1175
P407
P577
2005-05-01T00:00:00Z